Is there a place for β-mimetics in clinical management of neuropathic pain? salbutamol therapy in six cases

Anesthesiology

Volumn 112, Issue 5, 2010, Pages 1276-1279

  Cok, Oya Yalcin ^a   Eker, H Evren ^a   Yalcin, Ipek ^b   Barrot, Michel ^b   Aribogan, Anis ^a  

^a BASKENT UNIVERSITY   (Turkey)

^b CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; FENTANYL; GABAPENTIN; MUSCLE RELAXANT AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PREGABALIN; SALBUTAMOL; TRAMADOL; TRICYCLIC ANTIDEPRESSANT AGENT;

ABSENCE OF SIDE EFFECTS; ACUPUNCTURE; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; HUMAN; LUMBAR SPINAL STENOSIS; MALE; NEUROPATHIC PAIN; PAIN ASSESSMENT; PHYSIOTHERAPY; PRIORITY JOURNAL; RADICULOPATHY; SUSTAINED DRUG RELEASE; SYMPTOM; TREATMENT DURATION; VERTEBRAL CANAL STENOSIS;

EID: 77951665269     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e3181d40399     Document Type: Article

References (27)

1. Diatchenko L, Nackley AG, Slade GD, Bhalang K, Belfer I, Max MB, Goldman D, Maixner W: Catechol-O-methyltrans-ferase gene polymorphisms are associated with multiple pain-evoking stimuli. Pain 2006; 125:216-224
2. Diatchenko L, Slade GD, Nackley AG, Bhalang K, Sigurds-son A, Belfer I, Goldman D, Xu K, Shabalina SA, Shagin D: Genetic basis for individual variations in pain perception and the development of a chronic pain condition. Hum Mol Genet 2005; 14:135-143
3. Nackley AG, Tan KS, Fecho K, Flood P, Diatchenko L, Maixner W: Catechol-O-methyltransferase inhibition increases pain sensitivity through activation of both beta2-and beta3-adrenergic receptors. Pain 2007; 128:199-208
4. Diatchenko L, Anderson AD, Slade GD, Fillingim RB, Shab-alina SA, Higgins TJ, Sama S, Belfer I, Goldman D, Max MB: Three major haplotypes of the beta2 adrenergic receptor define psychological profile, blood pressure, and the risk for development of a common musculoskeletal pain disorder. Am J Med Genet B Neuropsychiatr Genet 2006; 141B: 449-462
5. Wood PB, Kablinger AS, Caldito GS: Open trial of pindolol in the treatment of fibromyalgia. Ann Pharmacother 2005; 39:1812-1816
6. Light KC, Bragdon EE, Grewen KM, Brownley KA, Girdler SS, Maixner W: Adrenergic dysregulation and pain with and without acute beta-blockade in women with fibromy-algia and temporomandibular disorder. J Pain 2009; 10: 542-552
7. Gur A, Oktayoglu P: Central nervous system abnormalities in fibromyalgia and chronic fatigue syndrome: New concepts in treatment. Curr Pharm Des 2008; 14:1274-1294
8. Loeser JD, Treede RD: The Kyoto protocol of IASP Basic Pain Terminology. Pain 2008; 137:473-477
9. Bouhassira D, Lantéri-Minet M, Attal N, Laurent B, Touboul C: Prevalence of chronic pain with neuropathic characteristics in the general population. Pain 2008; 136:380-387
10. Torrance N, Smith BH, Bennett MI, Lee AJ: The epidemiology of chronic pain of predominantly neuropathic origin. Results from a general population survey. J Pain 2006; 7:281-289
11. Dieleman JP, Kerklaan J, Huygen FJPM, Bouma PAD, Sturkenboom MCJM: Incidence rates and treatment of neuropathic pain conditions in the general population. Pain 2008; 137:681-688
12. Dworkin RH, O'Connor AB, Backonja M, Farrar JT, Finne-rup NB, Jensen TS, Kalso EA, Loeser JD, Miaskowski C, Nurmikko TJ: Pharmacologic management of neuropathic pain: Evidence-based recommendations. Pain 2007; 132: 237-251
13. Yalcin I, Tessier LH, Petit-Demoulière N, Doridot S, Hein L, Freund-Mercier MJ, Barrot M: Beta2-adrenoceptors are essential for desipramine, venlafaxine or reboxetine action in neuropathic pain. Neurobiol Dis 2009; 33:386-394
14. Yalcin I, Choucair-Jaafar N, Benbouzid M, Tessier LH, Mul-ler A, Hein L, Freund-Mercier MJ, Barrot M: Beta(2)-adre-noceptors are critical for antidepressant treatment of neuropathic pain. Ann Neurol 2009; 65:218-225
15. Barrot M, Yalcin I, Choucair-Jaafar N, Benbouzid M, Freund-Mercier MJ: From antidepressant drugs to beta-mimetics: Preclinical insights on potential new treatments for neuropathic pain. Recent Pat CNS Drug Discov 2009; 4:182-189
16. Choucair-Jaafar N, Yalcin I, Rodeau J, Waltisperger E, Freund-Mercier M, Barrot M:/32-Adrenoceptor agonists alleviate neuropathic allodynia in mice after chronic treatment. Br J Pharmacol 2009; 158:1683-1694
17. Yalcin I, Tessier LH, Petit-Demouliere N, Waltisperger E, Hein L, Freund-Mercier MJ, Barrot M: Chronic treatment with agonists of beta(2)-adrenergic receptors in neuropathic pain. Exp Neurol 2010; 221:115-121
18. Gursoy S, Erdal E, Herken H, Madenci E, Alaçsehirli B, Erdal N: Significance of catechol-O-methyltransferase gene polymorphism in fibromyalgia syndrome. Rheumatol Int 2003; 23:104-107 (Pubitemid 36712983)
19. Armero P, Muriel C, Santos J, Sanchez-Montero FJ, Rodríguez RE, Gonzalez-Sarmiento R: COMT (Val158Met) polymorphism is not associated to neuropathic pain in a Spanish population. Eur J Pain 2005; 9:229-232
20. Attal N, Cruccu G, Haanpaa M, Hansson P, Jensen TS, Nurmikko T, Sampaio C, Sindrup S, Wiffen P, EFNS Task Force: EFNS guidelines on pharmacological treatment of neuropathic pain. Eur J Neurol 2006; 13:1153-1169
21. Baron R: Mechanisms of disease: Neuropathic pain-A clinical perspective. Nat Clin Pract Neurol 2006; 2:95-106
22. Attal N, Fermanian C, Fermanian J, Lanteri-Minet M, Al-chaar H, Bouhassira D: Neuropathic pain: Are there distinct subtypes depending on the aetiology or anatomical lesion? Pain 2008; 138:343-353
23. Davis MP: What is new in neuropathic pain? Support Care Cancer 2007; 15:363-372
24. Segerdahl M: Improving early clinical drug development for neuropathic pain by improving patient selection. Pain 2009; 141:4-5
25. Zieglgansberger W, Berthele A, Tolle TR: Understanding neuropathic pain. CNS Spectr 2005; 10:298-308
26. Gidal BE: New and emerging treatment options for neuropathic pain. Am J Manag Care 2006; 12:S269-78
27. Mattia C, Paoletti F, Coluzzi F, Boanelli A: New antidepressants in the treatment of neuropathic pain. A review. Minerva Anestesiol 2002; 68:105-114 (Pubitemid 41739203)